Role of interleukin-15 in umbilical cord blood transplantation

International Reviews of Immunology

Volumn 27, Issue 6, 2008, Pages 518-531

  Lin, Syh Jae ^a   Yan, Dah Chin ^a   Lee, Yen Chang ^a   Kuo, Ming Ling ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Interleukin 15; Natural killer cells; T cells; Umbilical cord blood

Indexed keywords

INTERLEUKIN 15;

CELL FUNCTION; CORD BLOOD STEM CELL TRANSPLANTATION; DENDRITIC CELL; DRUG MECHANISM; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; INFECTION SENSITIVITY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOMEOSTASIS; HUMANS; INTERLEUKIN-15; STEM CELL NICHE; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 57449110048     PISSN: 08830185     EISSN: 15635244     Source Type: Journal    
DOI: 10.1080/08830180802317940     Document Type: Review

References (106)

1. J.A. Brown and V.A. Boussiotis, Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol 2008.
2. J. Wagner, R. Champlin, and L.D. Petz, Fifth Annual International Umbilical Cord Blood Transplantation Symposium, Los Angeles, California, May 11-12, 2007. Biol Blood Marrow Transplant 13: 1380-1392, 2007.
3. C.G. Brunstein, K.S. Baker, and J.E. Wagner, Umbilical cord blood transplantation for myeloid malignancies. Curr Opin Hematol 14: 162-169, 2007.
4. J.E. Wagner, J.N. Barker, T.E. DeFor, K.S. Baker, B.R. Blazar, C. Eide, A. Goldman, J. Kersey, W. Krivit, M.L. MacMillan, P.J. Orchard, C. Peters, D.J. Weisdorf, N.K. Ramsay, and S.M. Davies, Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100: 1611-1618, 2002.
5. C.G. Brunstein, D.C. Setubal, and J.E. Wagner, Expanding the role of umbilical cord blood transplantation. Br J Haematol 137: 20-35, 2007.
6. V. Rocha, G. Sanz, and E. Gluckman, Umbilical cord blood transplantation. Curr Opin Hematol 11: 375-385, 2004.
7. V. Rocha, J.E. Wagner, Jr., K.A. Sobocinski, J.P. Klein, M.J. Zhang, M.M. Horowitz, and E. Gluckman, Graft-versus-host disease in children who have received a cordblood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med 342: 1846-1854, 2000.
8. P. Rubinstein, C. Carrier, A. Scaradavou, J. Kurtzberg, J. Adamson, A.R. Migliaccio, R.L. Berkowitz, M. Cabbad, N.L. Dobrila, P.E. Taylor, R.E. Rosenfield, and C.E. Stevens, Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339: 1565-1577, 1998.
9. M.J. Laughlin, M. Eapen, P. Rubinstein, J.E. Wagner, M.J. Zhang, R.E. Champlin, C. Stevens, J.N. Barker, R.P. Gale, H.M. Lazarus, D.I. Marks, J.J. van Rood, A. Scaradavou, and M.M. Horowitz, Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351: 2265-2275, 2004.
10. K.M. Williams, F.T. Hakim, and R.E. Gress, T cell immune reconstitution following lymphodepletion. Semin Immunol 19: 318-330, 2007.
11. K.V. Komanduri, L.S. St. John, M. de Lima, J. McMannis, S. Rosinski, I. McNiece, S.G. Bryan, I. Kaur, S. Martin, E.D. Wieder, L. Worth, L.J. Cooper, D. Petropoulos, J.J. Molldrem, R.E. Champlin, and E.J. Shpall, Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood 110: 4543-4551, 2007.
12. J.A. van Burik and C.G. Brunstein, Infectious complications following unrelated cord blood transplantation. Vox Sang 92: 289-296, 2007.
13. C.L. Yao and S.M. Hwang, Ex vivo expansion of hematopoietic stem cells from human cord blood in serum-free conditions. Methods Mol Biol 407: 165-175, 2007.
14. Y. Wei, Y. Huang, Y. Zhang, H. Zhou, Q. Cao, Q. Meng, J. Lan, and L. Chen, Ex vivo expansion of CD34(+) and T and NK cells from umbilical cord blood for leukemic BALB/C nude mouse transplantation. Int J Hematol 87: 217-224, 2008.
15. J.F. Hutton, R. J. D'Andrea, and I.D. Lewis, Potential for clinical ex vivo expansion of cord blood haemopoietic stem cells using non-haemopoietic factor supplements. Curr Stem Cell Res Ther 2: 229-237, 2007.
16. C.C. Hofmeister, J. Zhang, K.L. Knight, P. Le, and P.J. Stiff, Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant 39: 11-23, 2007.
17. J.N. Barker, D.J. Weisdorf, T.E. DeFor, B.R. Blazar, P.B. McGlave, J.S. Miller, C.M. Verfaillie, and J.E. Wagner, Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105: 1343-1347, 2005.
18. K.K. Ballen, T.R. Spitzer, B.Y. Yeap, S. McAfee, B.R. Dey, E. Attar, R. Haspel, G. Kao, D. Liney, E. Alyea, S. Lee, C. Cutler, V. Ho, R. Soiffer, and J.H. Antin, Double unrelated reduced-intensity umbilical cord blood transplantation in adults. Biol Blood Marrow Transplant 13: 82-89, 2007.
19. M.J. Laughlin, J. Barker, B. Bambach, O.N. Koc, D.A. Rizzieri, J.E. Wagner, S.L. Gerson, H.M. Lazarus, M. Cairo, C.E. Stevens, P. Rubinstein, and J. Kurtzberg, Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 344: 1815-1822, 2001.
20. J.M. Morgado, R. Pratas, P. Laranjeira, A. Henriques, I. Crespo, F. Regateiro, and A. Paiva, The phenotypical and functional characteristics of cord blood monocytes and CD14(-/low)/CD16(+) dendritic cells can be relevant to the development of cellular immune responses after transplantation. Transpl Immunol 19: 55-63, 2008.
21. A. Encabo, P. Solves, F. Carbonell-Uberos, and M.D. Minana, The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation. Transfusion 47: 272-279, 2007.
22. M.B. Bradley and M.S. Cairo, Cord blood immunology and stem cell transplantation. Hum Immunol 66: 431-446, 2005.
23. S.J. Lin, J.C. Yu, P.J. Cheng, S.S. Hsiao, and M.L. Kuo, Effect of interleukin-15 on anti-CD3/anti-CD28 induced apoptosis of umbilical cord blood CD4+ T cells. Eur J Haematol 71: 425-432, 2003.
24. S. Kadereit, S.F. Mohammad, R.E. Miller, K.D. Woods, C.D. Listrom, K. McKinnon, A. Alali, L.S. Bos, M.L. Iacobucci, M.R. Sramkoski, J.W. Jacobberger, and M.J. Laughlin, Reduced NFAT1 protein expression in human umbilical cord blood T lymphocytes. Blood 94: 3101-3107, 1999.
25. S.J. Lin and P.J. Cheng, Effect of interleukin-7 and -15 on activation of purified umbilical cord blood and adult peripheral blood CD4+ T cells. Biol Neonate 85: 3-10, 2004.
26. E. Canto, J.L. Rodriguez-Sanchez, and S. Vidal, Naive CD4+ cells from cord blood can generate competent Th effector cells. Transplantation 80: 850-858, 2005.
27. E. Canto, J.L. Rodriguez-Sanchez, and S. Vidal, Distinctive response of naive lymphocytes from cord blood to primary activation via TCR.JLeukocBiol 74: 998-1007, 2003.
28. F.M. Kloosterboer, S.A. van Luxemburg-Heijs, R. Willemze, and J.H. Falkenburg, Similar potential to become activated and proliferate but differential kinetics and profiles of cytokine production of umbilical cord blood T cells and adult blood naive and memory T cells. Hum Immunol 67: 874-883, 2006.
29. S.J. Lin, L.Y. Wang, Y.J. Huang, and M.L. Kuo, Effect of interleukin (IL)-12 and IL-15 on apoptosis and proliferation of umbilical cord blood mononuclear cells. Bone Marrow Transplant 28: 439-445, 2001.
30. M. Hagihara, J. Chargui, B. Gansuvd, F. Tsuchida, T. Sato, T. Hotta, and S. Kato, Umbilical cord blood T lymphocytes are induced to apoptosis after being allo-primed in vitro. Bone Marrow Transplant 24: 1229-1233, 1999.
31. A. El Ghalbzouri, B. Drenou, V. Blancheteau, C. Choqueux, R. Fauchet, D. Charron, and N. Mooney, An in vitro model of allogeneic stimulation of cord blood: induction of Fas independent apoptosis. Hum Immunol 60: 598-607, 1999.
32. S. Aggarwal, A. Gupta, S. Nagata, and S. Gupta, Programmed cell death (apoptosis) in cord blood lymphocytes. J Clin Immunol 17: 63-73, 1997.
33. S.J. Lin, P.J. Cheng, S.S. Hsiao, H.H. Lin, P.F. Hung, and M.L. Kuo, Differential effect of IL-15 and IL-2 on survival of phytohemagglutinin- activated umbilical cord blood T cells. Am J Hematol 80: 106-112, 2005.
34. J. Wu and L.L. Lanier, Natural killer cells and cancer. Adv Cancer Res 90: 127-156, 2003.
35. S.S. Farag, J.B. VanDeusen, T.A. Fehniger, and M.A. Caligiuri, Biology and clinical impact of human natural killer cells. Int J Hematol 78: 7-17, 2003.
36. L. Moretta, M.C. Mingari, C. Bottino, D. Pende, R. Biassoni, and A. Moretta, Cellular and molecular basis of natural killer and natural killer-like activity. Immunol Lett 88: 89-93, 2003.
37. L. Ruggeri, M. Capanni, E. Urbani, K. Perruccio, W.D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, F. Aversa, M.F. Martelli, and A.Velardi, Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295: 2097-2100, 2002.
38. J. Clausen, D. Wolf, A.L. Petzer, E. Gunsilius, P. Schumacher, B. Kircher, G. Gastl, and D. Nachbaur, Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation. Clin Exp Immunol 148: 520-528, 2007.
39. S.S. Farag, A. Bacigalupo, M. Eapen, C. Hurley, B. Dupont, M.A. Caligiuri, C. Boudreau, G. Nelson, M. Oudshoorn, J. van Rood, A. Velardi, M. Maiers, M. Setterholm, D. Confer, P.E. Posch, C.Anasetti, N. Kamani, J.S. Miller, D. Weisdorf, and S.M. Davies, The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. Biol Blood Marrow Transplant 12: 876-884, 2006.
40. K.J. Malmberg, M. Schaffer, O. Ringden, M. Remberger, and H.G. Ljunggren, KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation. Mol Immunol 42: 531-534, 2005.
41. J.H. Dalle, J. Menezes, E. Wagner, M. Blagdon, J. Champagne, M.A. Champagne, and M. Duval, Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections. Pediatr Res 57: 649-655, 2005.
42. Q.H. Nguyen, R.L. Roberts, B.J. Ank, S.J. Lin, E.K. Thomas, and E.R. Stiehm, Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells. Cell Immunol 185: 83-92, 1998.
43. S.J. Lin, M.H. Yang, H.C. Chao, M.L. Kuo, and J.L. Huang, Effect of interleukin-15 and Flt3-ligand on natural killer cell expansion and activation: umbilical cord vs. adult peripheral blood mononuclear cells. Pediatr Allergy Immunol 11: 168-174, 2000.
44. S.J. Lin, P.J. Cheng, Y.J. Huang, and M.L. Kuo, Evaluation of cytotoxic function and apoptosis in interleukin (IL)-12/IL-15-treated umbilical cord or adult peripheral blood natural killer cells by a propidium-iodide based flow cytometry. Pediatr Allergy Immunol 15: 79-85, 2004.
45. H. Tanaka, S. Kai, M. Yamaguchi, M. Misawa, Y. Fujimori, M. Yamamoto, and H. Hara, Analysis of natural killer (NK) cell activity and adhesion molecules on NK cells from umbilical cord blood. Eur J Haematol 71: 29-38, 2003.
46. Z. Brahmi, G. Hommel-Berrey, F. Smith, and B. Thomson, NK cells recover early andmediate cytotoxicity via perforin/granzyme and Fas/FasL pathways in umbilical cord blood recipients. Hum Immunol 62: 782-790, 2001.
47. A. Lundqvist, J.P. McCoy, L. Samsel, and R. Childs, Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors. Blood 109: 3603-3606, 2007.
48. L. Ruggeri, A. Mancusi, E. Burchielli, M. Capanni, A. Carotti, T. Aloisi, F. Aversa, M.F. Martelli, and A. Velardi, NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. Blood Cells Mol Dis 40: 84-90, 2008.
49. S. Nguyen, N. Dhedin, J.P. Vernant, M. Kuentz, A. Al Jijakli, N. Rouas-Freiss, E.D. Carosella, A. Boudifa, P. Debre, and V. Vieillard, NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood 105: 4135-4142, 2005.
50. N. Musha, Y. Yoshida, S. Sugahara, S. Yamagiwa, T. Koya, H. Watanabe, K. Hatakeyama, and T. Abo, Expansion of CD56+ NK T and gamma delta T cells from cord blood of human neonates. Clin Exp Immunol 113: 220-228, 1998.
51. B.A. Collin, H.L. Leather, J.R. Wingard, and R. Ramphal, Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 33: 947-953, 2001.
52. C.C. Chang, P. Satwani, N. Oberfield, G. Vlad, L.L. Simpson, and M.S. Cairo, Increased induction of allogeneic-specific cord blood CD4+CD25+ regulatory T (Treg) cells: a comparative study of naive and antigenic-specific cord blood Treg cells. Exp Hematol 33: 1508-1520, 2005.
53. W.R. Godfrey, D.J. Spoden, Y.G. Ge, S.R. Baker, B. Liu, B.L. Levine, C.H. June, B.R. Blazar, and S.B. Porter, Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 105: 750-758, 2005.
54. C.L. Mackall and R.E. Gress, Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol Rev 157: 61-72, 1997.
55. B.J. Chen, X. Cui, G.D. Sempowski, and N.J. Chao, Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice. Exp Hematol 31: 953-958, 2003.
56. O. Alpdogan, S.J. Muriglan, B.J. Kappel, E. Doubrovina, C. Schmaltz, R. Schiro, J.M. Eng, A.S. Greenberg, L.M. Willis, J.A. Rotolo, R.J. O'Reilly, and M.R. van den Brink, Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantation. Transplantation 75: 1977-1983, 2003.
57. O. Alpdogan, V.M. Hubbard, O.M. Smith, N. Patel, S. Lu, G.L. Goldberg, D.H. Gray, J. Feinman, A.A. Kochman, J.M. Eng, D. Suh, S.J. Muriglan, R.L. Boyd, and M.R. van den Brink, Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood 107: 2453-2460, 2006.
58. R. Seggewiss, K. Lore, F.J. Guenaga, S. Pittaluga, J. Mattapallil, C.K. Chow, R.A. Koup, K. Camphausen, M.C. Nason, M. Meier-Schellersheim, R.E. Donahue, B.R. Blazar, C.E. Dunbar, and D.C. Douek, Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. Blood 110: 441-449, 2007.
59. J.S. Sutherland, G.L. Goldberg, M.V. Hammett, A.P. Uldrich, S.P. Berzins, T.S. Heng, B.R. Blazar, J.L. Millar, M.A. Malin, A.P. Chidgey, and R.L. Boyd, Activation of thymic regeneration in mice and humans following androgen blockade. J Immunol 175: 2741-2753, 2005.
60. G.L. Goldberg, O. Alpdogan, S.J. Muriglan, M.V. Hammett, M.K. Milton, J.M. Eng, V.M. Hubbard, A. Kochman, L.M. Willis, A.S. Greenberg, K.H. Tjoe, J.S. Sutherland, A. Chidgey, M.R. van den Brink, and R.L. Boyd, Enhanced immune reconstitution by sex steroid ablation following allogeneic hemopoietic stem cell transplantation. J Immunol 178: 7473-7484, 2007.
61. O. Alpdogan, S.J. Muriglan, J.M. Eng, L.M. Willis, A.S. Greenberg, B.J. Kappel, and M.R. van den Brink, IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation. J Clin Invest 112: 1095-1107, 2003.
62. S.A. Rosenberg, C. Sportes, M. Ahmadzadeh, T.J. Fry, L.T. Ngo, S.L. Schwarz, M. Stetler-Stevenson, K.E. Morton, S.A. Mavroukakis, M. Morre, R. Buffet, C.L. Mackall, and R.E. Gress, IL-7 administration to humans leads to expansion of CD8 + and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother 29: 313-319, 2006.
63. K.H. Grabstein, J. Eisenman, K. Shanebeck, C. Rauch, S. Srinivasan, V. Fung, C. Beers, J. Richardson, M.A. Schoenborn, M. Ahdieh, et al., Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science 264: 965-968, 1994.
64. J.G. Giri, D.M. Anderson, S. Kumaki, L.S. Park, K.H. Grabstein, and D. Cosman, IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leukoc Biol 57: 763-766, 1995.
65. W.E. Carson, T.A. Fehniger, S. Haldar, K. Eckhert, M.J. Lindemann, C.F. Lai, C.M. Croce, H. Baumann, and M.A. Caligiuri, A potential role for interleukin-15 in the regulation of human natural killer cell survival. J Clin Invest 99: 937-943, 1997.
66. T. Ranson, C.A. Vosshenrich, E. Corcuff, O. Richard, W. Muller, and J.P. Di Santo, IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 101: 4887-4893, 2003.
67. C.C. Liu, B. Perussia, and J.D. Young, The emerging role of IL-15 in NK-cell development. Immunol Today 21: 113-116, 2000.
68. M.K. Kennedy, M. Glaccum, S.N. Brown, E.A. Butz, J.L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C.R. Willis, K. Brasel, P.J. Morrissey, K. Stocking, J.C. Schuh, S. Joyce, and J.J. Peschon, Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 191: 771-780, 2000.
69. M. Berard, K. Brandt, S. Bulfone-Paus, and D.F. Tough, IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J Immunol 170: 5018-5026, 2003.
70. J. Marks-Konczalik, S. Dubois, J.M. Losi , H. Sabzevari, N. Yamada, L. Feigenbaum, T.A. Waldmann, and Y. Tagaya, IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci USA 97: 11445-11450, 2000.
71. T.A. Waldmann, S. Dubois, and Y. Tagaya, Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapyImmunity 14: 105-110, 2001.
72. X. Zhang, S. Sun, I. Hwang, D.F. Tough, and J. Sprent, Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8: 591-599, 1998.
73. J.X. Qian, S.M. Lee, Y. Suen, E. Knoppel, C. van de Ven, and M.S. Cairo, Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood 90: 3106-3117, 1997.
74. Y. Wang, X. Zheng, H. Wei, R. Sun, and Z. Tian, Different roles of IL-15 from IL-2 in differentiation and activation of human CD3(+)CD56(+) NKT-like cells from cord blood in long term culture. Int Immunopharmacol 8: 927-934, 2008.
75. F.T. Hakim, R. Cepeda, S. Kaimei, C.L. Mackall, N. McAtee, J. Zujewski, K. Cowan, and R.E. Gress, Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 90: 3789-3798, 1997.
76. N.L. Alves, B. Hooibrink, F.A. Arosa, and R.A. van Lier, IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro. Blood 102: 2541-2546, 2003.
77. H. Yamada, T. Nakamura, G. Matsuzaki, Y. Iwamoto, and K. Nomoto, TCR-independent activation of extrathymically developed, self antigen-specific T cells by IL-2/IL-15. J Immunol 164: 1746-1752, 2000.
78. Y. Li, W. Zhi, P. Wareski, and N.P. Weng, IL-15 activates telomerase and minimizes telomere loss and may preserve the replicative life span of memory CD8+ T cells in vitro. J Immunol 174: 4019-4024, 2005.
79. O. Alpdogan, J.M. Eng, S.J. Muriglan, L.M. Willis, V.M. Hubbard, K.H. Tjoe, T.H. Terwey, A. Kochman, and M.R. van den Brink, Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation. Blood 105: 865-873, 2005.
80. S. Rutella, L. Pierelli, G. Bonanno, A. Mariotti, S. Sica, F. Sora, P. Chiusolo, G. Scambia, C. Rumi, and G. Leone, Immune reconstitution after autologous peripheral blood progenitor cell transplantation: effect of interleukin-15 on T-cell survival and effector functions. Exp Hematol 29: 1503-1516, 2001.
81. B.W. Blaser, S. Roychowdhury, D.J. Kim, N.R. Schwind, D. Bhatt, W. Yuan, D.F. Kusewitt, A.K. Ferketich, M.A. Caligiuri, and M. Guimond, Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease. Blood 105: 894-901, 2005.
82. S. Roychowdhury, B.W. Blaser, A.G. Freud, K. Katz, D. Bhatt, A.K. Ferketich, V. Bergdall, D. Kusewitt, R.A. Baiocchi, and M.A. Caligiuri, IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease. Blood 106: 2433-2435, 2005.
83. S. Kumaki, M. Minegishi, H. Fujie, Y. Sasahara, Y. Ohashi, S. Tsuchiya, and T. Konno, Prolonged secretion of IL-15 in patients with severe forms of acute graft-versus-host disease after allogeneic bone marrow transplantation in children. Int J Hematol 67: 307-312, 1998.
84. K.W. Chik, K. Li, H. Pong, M.M. Shing, C.K. Li, and P.M. Yuen, Elevated serum interleukin-15 level in acute graft-versus-host disease after hematopoietic cell transplantation. J Pediatr Hematol Oncol 25: 960-964, 2003.
85. S.J. Lin, P.J. Cheng, D.C. Yan, P.T. Lee, and H.S. Hsaio, Effect of interleukin-15 on alloreactivity in umbilical cord blood. Transpl Immunol 16: 112-116, 2006.
86. S.L. Goldberg, A.L. Pecora, R.J. Rosenbluth, A.A. Jennis, and R.A. Preti, Treatment of leukemic relapse following unrelated umbilical cord blood transplantation with interleukin-2: potential for augmenting graft-versus-leukemia and graft-versus-host effects with cytokines. Bone Marrow Transplant 26: 353-355, 2000.
87. B. Sprangers, S. Fevery, B. VanWijmeersch, L. De Somer, M. Waer, and A.D. Billiau, Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease? Front Biosci 12: 4568-4594, 2007.
88. A. Schulze, H. Schirutschke, U. Oelschlagel, M. Schmitz, M. Fussel, R. Wassmuth, G. Ehninger, M. Bornhauser, and U. Platzbecker, Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation. Exp Hematol 36: 378-389, 2008.
89. X. Lu, Y. Kondo, H. Takamatsu, K. Ohata, H. Yamazaki, A. Takami, Y. Akatsuka, and S. Nakao, CD16(+) CD56(-) NK cells in the peripheral blood of cord blood transplant recipients: a unique subset of NK cells possibly associated with graft-versus-leukemia effect. Eur J Haemato 2008.
90. S.S. Choi, V.S. Chhabra, Q.H. Nguyen, B.J. Ank, E.R. Stiehm, and R.L. Roberts, Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture. Clin Diagn Lab Immunol 11: 879-888, 2004.
91. M. Boyiadzis, S. Memon, J. Carson, K. Allen, M.J. Szczepanski, B.A. Vance, R. Dean, M.R. Bishop, R.E. Gress, and F.T. Hakim, Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels. Biol Blood Marrow Transplant 14: 290-300, 2008.
92. C.A. Biron, K.B. Nguyen, G.C. Pien, L.P. Cousens, and T.P. Salazar-Mather, Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17: 189-220, 1999.
93. L. Zitvogel. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J Exp Med 195: F9-14, 2002.
94. T.C. Becker, E.J. Wherry, D. Boone, K. Murali-Krishna, R. Antia, A. Ma, and R. Ahmed, Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med 195: 1541-1548, 2002.
95. K.S. Schluns, K. Williams, A. Ma, X.X. Zheng, and L. Lefrancois, Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol 168: 4827-4831, 2002.
96. A. Ahmad, E. Sharif-Askari, L. Fawaz, and J. Menezes, Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction. J Virol 74: 7196-7203, 2000.
97. N. Gill, K.L. Rosenthal, and A.A. Ashkar, NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection. J Virol 79: 4470-4478, 2005.
98. Y. Kagimoto, H. Yamada, T. Ishikawa, N. Maeda, F. Goshima, Y. Nishiyama, M. Furue, and Y. Yoshikai, A regulatory role of interleukin 15 in wound healing and mucosal infection in mice. J Leukoc Biol 83: 165-172, 2008.
99. T. Yajima, H. Nishimura, R. Ishimitsu, K. Yamamura, T. Watase, D.H. Busch, E.G. Pamer, H. Kuwano, and Y. Yoshikai, Memory phenotype CD8(+) T cells in IL-15 transgenic mice are involved in early protection against a primary infection with Listeria monocytogenes. Eur J Immunol 31: 757-766, 2001.
100. K. Saito, T. Yajima, S. Kumabe, T. Doi, H. Yamada, S. Sad, H. Shen, and Y. Yoshikai, Impaired protection against Mycobacterium bovis bacillus Calmette-Guerin infection in IL-15-deficient mice. J Immunol 176: 2496-2504, 2006.
101. S.J. Lin, R.L. Roberts, B.J. Ank, Q.H. Nguyen, E.K. Thomas, and E.R. Stiehm, Human immunodeficiency virus (HIV) type-1 GP120-specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected (HIV+) subjects: enhancement with interleukin-2 (IL-2), IL-12, and IL-15. Clin Immunol Immunopathol 82: 163-173, 1997.
102. S.J. Lin, R.L. Roberts, B.J. Ank, Q.H. Nguyen, E.K. Thomas, and E.R. Stiehm, Effect of interleukin (IL)-12 and IL-15 on activated natural killer (ANK) and antibody-dependent cellular cytotoxicity (ADCC) in HIV infection. J Clin Immunol 18: 335-345, 1998.
103. Y.M. Mueller, P.M. Bojczuk, E.S. Halstead, A.H. Kim, J. Witek, J.D. Altman, and P.D. Katsikis, IL-15 enhances survival and function of HIV-specific CD8 + T cells. Blood 101: 1024-1029, 2003.
104. G. d'Ettorre, G. Forcina, M. Lichtner, F. Mengoni, C. D'Agostino, A.P. Massetti, C.M. Mastroianni, and V. Vullo, Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients. AIDS 16: 181-188, 2002.
105. N.S. Hamza, M. Lisgaris, G. Yadavalli, L. Nadeau, R. Fox, P. Fu, H.M. Lazarus, O.N. Koc, R.A. Salata, and M.J. Laughlin, Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 124: 488-498, 2004.
106. G. Cohen, S.L. Carter, K.I. Weinberg, B. Masinsin, E. Guinan, J. Kurtzberg, J.E. Wagner, N.A. Kernan, and R. Parkman, Antigen-specific T-lymphocyte function after cord blood transplantation. Biol Blood Marrow Transplant 12: 1335-1342, 2006.